Status:
RECRUITING
Multimodal and Multidisciplinary Approach to Optimize Diagnostic, Prognostic, and Therapeutic Management of Patients with Non-ischemic Cardiomyopathies and Arrhythmogenic-inflammatory Phenotypes: a Multicenter, Observational, Retrospective and Prospective Registry Study.
Lead Sponsor:
Scientific Institute San Raffaele
Conditions:
Non-ischemic Cardiomyopathy
Dilated Cardiomyopathy (DCM)
Eligibility:
All Genders
18+ years
Brief Summary
Non-ischemic cardiomyopathies (NICM) represent a heterogeneous group of pathologies characterized by absence of obstructive disease of the epicardial coronary vessels and distinct structural and funct...
Detailed Description
This study aims to collect clinical data of both retrospective and prospective patients with suspected or proven NICMs in a registry. The scope of the registry is to answer multiple unsolved questions...
Eligibility Criteria
Inclusion
- Written informed consent. For pediatric patients, consent will be obtained by parents, according to the laws applicable in each of the participating countries.
- Clinical suspicion of NICM, and/or proven diagnosis of any NICM and/or genotype consistent with any NICM.
- NICMs will include but not limit to: DCM, HCM, RCM, ACM, inflammatory, infiltrative, dysmetabolic, mitochondrial, toxic, neuromuscular, rheumatologic/autoimmune cardiomyopathies, channelopathies with structural substrates, LVNC, PPCM, AMVP, AFD, athlete's heart, undefined and overlap cardiomyopathies. Additional diseases of the NICM spectrum will be included in parallel with the advance of the current knowledge.
Exclusion
- Absent informed consent.
- Proven diagnosis of cardiac disease alternative to NICM.
- Lack of diagnostic workup suitable for diagnosing NICM, detecting arrhythmias, or detecting M-Infl.
- For patients retrospectively enrolled: lack of active status of follow-up at the enrolling center.
Key Trial Info
Start Date :
January 30 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2035
Estimated Enrollment :
15000 Patients enrolled
Trial Details
Trial ID
NCT06607471
Start Date
January 30 2018
End Date
December 31 2035
Last Update
September 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS San Raffaele Scientific Institute
Milan, Milano, Italy, 20132